House Sunscreen Bill Advances, But TEA Review Deadlines In Question
This article was originally published in The Rose Sheet
Executive Summary
The House Energy and Commerce Health subcommittee unanimously advanced the Sunscreen Innovation Act to full committee June 19, but provisions in the original bill seeking a tight timeline for FDA’s review of sunscreen ingredient time-and-extent applications are now in limbo, according to the Public Access to Sunscreens coalition of stakeholders.